QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$49.75−0.06 (-0.12%)
Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%
Qiagen cash
Cash and short-term investments held at the end of each period.
Qiagen's cash was $1.10B at Dec 31, 2025. For fiscal 2025 it was $1.10B, down 4.7% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $1.42B in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | -4.7% |
| FY2024 | Dec 31, 2024 | $1.15B | +9.0% |
| FY2023 | Dec 31, 2023 | $1.06B | -25.4% |
| FY2022 | Dec 31, 2022 | $1.42B | +33.1% |
| FY2021 | Dec 31, 2021 | $1.07B | +48.9% |
| FY2020 | Dec 31, 2020 | $715.23M | -5.8% |
| FY2019 | Dec 31, 2019 | $758.98M | -45.5% |
| FY2018 | Dec 31, 2018 | $1.39B | +37.1% |
| FY2017 | Dec 31, 2017 | $1.02B | +91.1% |
| FY2016 | Dec 31, 2016 | $532.18M | +26.5% |
| FY2015 | Dec 31, 2015 | $420.83M | -27.0% |
| FY2014 | Dec 31, 2014 | $576.70M | +51.7% |
| FY2013 | Dec 31, 2013 | $380.23M | -21.5% |
| FY2012 | Dec 31, 2012 | $484.49M | +75.7% |
| FY2011 | Dec 31, 2011 | $275.71M | -70.5% |
| FY2010 | Dec 31, 2010 | $934.48M | +8.0% |
| FY2009 | Dec 31, 2009 | $865.56M | +159.7% |
| FY2008 | Dec 31, 2008 | $333.31M | -4.0% |
| FY2007 | Dec 31, 2007 | $347.32M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $1.10B | +3.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.15B | +61.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.06B | +39.4% |
| Q4 FY2022 | Dec 31, 2022 | $1.42B | +1.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.07B | +4.8% |
| Q4 FY2020 | Dec 31, 2020 | $715.23M | +34.4% |
| Q4 FY2019 | Dec 31, 2019 | $758.98M | +80.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.39B | +141.7% |
| Q4 FY2017 | Dec 31, 2017 | $1.02B | +167.4% |
| Q4 FY2016 | Dec 31, 2016 | $532.18M | +9.8% |
| Q4 FY2015 | Dec 31, 2015 | $420.83M | +52.6% |
| Q4 FY2014 | Dec 31, 2014 | $576.70M | -38.3% |
| Q4 FY2013 | Dec 31, 2013 | $380.23M | -56.1% |
| Q4 FY2012 | Dec 31, 2012 | $484.49M | +45.4% |
| Q4 FY2011 | Dec 31, 2011 | $275.71M | -20.6% |
| Q4 FY2010 | Dec 31, 2010 | $934.48M | – |
| Q4 FY2009 | Dec 31, 2009 | $865.56M | – |
| Q4 FY2008 | Dec 31, 2008 | $333.31M | – |
| Q4 FY2007 | Dec 31, 2007 | $347.32M | – |
See a number that looks wrong?